NEW YORK(GenomeWeb) – A study sponsored by Astute Medical has found that the company's NephroCheck test for acute kidney injury is also predictive of adverse long term outcomes in AKI patients.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.